188532-62-9 Usage
Uses
Used in Pharmaceutical Research:
2,4-dibromo-N-(4-methoxybenzyl)butanamide serves as an intermediate in organic synthesis and pharmaceutical research, playing a crucial role in the development of new drugs. Its potential applications in this field stem from its ability to act as a building block in the synthesis of various bioactive molecules, contributing to the advancement of medicinal chemistry.
Used in Organic Synthesis:
In the realm of organic synthesis, 2,4-dibromo-N-(4-methoxybenzyl)butanamide is utilized as a key intermediate. Its presence of bromine atoms allows for versatile chemical reactions, facilitating the creation of a wide array of compounds with potential applications across different industries.
Used in Drug Discovery:
2,4-dibromo-N-(4-methoxybenzyl)butanamide is also instrumental in drug discovery, where its reactivity and selectivity are harnessed to design and synthesize novel therapeutic agents. This makes it an indispensable tool for researchers working on the next generation of pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 188532-62-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,8,5,3 and 2 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 188532-62:
(8*1)+(7*8)+(6*8)+(5*5)+(4*3)+(3*2)+(2*6)+(1*2)=169
169 % 10 = 9
So 188532-62-9 is a valid CAS Registry Number.
188532-62-9Relevant academic research and scientific papers
Cobalt-Catalyzed α-Arylation of Substituted α-Bromo α-Fluoro β-Lactams with Diaryl Zinc Reagents: Generalization to Functionalized Bromo Derivatives
Br?se, Stefan,Chen, Hi-Yung,Cossy, Janine,Koch, Vanessa,Lei, Aiwen,Lorion, Mélanie M.,Nieger, Martin
supporting information, p. 13163 - 13169 (2020/09/23)
A cobalt-catalyzed cross-coupling of α-bromo α-fluoro β-lactams with diarylzinc or diallylzinc reagents is herein disclosed. The protocol proved to be general, chemoselective and operationally simple allowing the C4 functionalization of β-lactams. The substrate scope was expanded to α-bromo lactams and amides, α-bromo lactones and esters as well as N- and O-containing heterocycles.
Cephalosporin derivatives
-
, (2008/06/13)
The present invention relates to compounds of formula I STR1 wherein R1 is a group selected from 2-, 3-, and 4-hydroxyphenyl, 3-nitrophenyl, and 3-fluoro-4-hydroxyphenyl; as well as readily hydroyzable esters thereof, pharmaceutically acceptabl
